BASF SE ADR Stock
Price
Target price
€12.30
€12.30
-4.650%
-0.6
-4.650%
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
BASF SE ADR Stock
Heavy losses for BASF SE ADR today as the stock fell by -€0.600 (-4.650%).
Pros and Cons of BASF SE ADR in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
S********** s********
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of BASF SE ADR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| BASF SE ADR | -4.650% | -0.806% | 6.957% | 9.821% | 13.889% | 0.000% | -30.114% |
| Groupe Bruxelles Lambert S.A. | 0.570% | 3.396% | -5.718% | 11.636% | 4.008% | 0.572% | -11.406% |
| Covestro AG | -0.230% | 0.134% | -1.357% | 1.533% | -0.931% | 56.155% | 3.976% |
| Henkel AG & Co. KGaA VZO | -1.420% | -3.607% | -19.287% | -10.685% | -6.644% | -9.419% | -31.613% |
Comments
Basf (BASFY) was upgraded by Deutsche Bank Aktiengesellschaft from "hold" to "buy".
Show more
Ratings data for BASFY provided by MarketBeat
Basf (BASFY) had its "buy" rating reaffirmed by Citigroup Inc..
Show more
Ratings data for BASFY provided by MarketBeat
Basf (OTCMKTS:BASFY) was downgraded by analysts at Barclays PLC to an "underweight" rating.
Show more
Ratings data for BASFY provided by MarketBeat
News
AirJoule on Commercialization Path: Sales Will Start Soon
The biggest hurdle for AirJoule Technologies (NASDAQ: AIRJ) and its investors is the transition to commercialization, but it looks to be an easy hurdle to cross. The fiscal Q4 results reveal the
AirJoule Has Big Partners—So What’s Still Holding the Stock Back?
AirJoule Technologies (NASDAQ: AIRJ) is a risky play, as it is a pre-revenue company yet to start sales, which are expected to begin in 2026. The questions are whether the company matters, if its